References
- 1. Zirngibl L – Antifungal azoles: a comprehensive survey of their structures and properties. Weinheim: Wiley-VCH; 1998, 85-86.
- 2. Beale Jr. JM – Anti-infective Agents, in Beale Jr. JM, Block JH (eds.): Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry. Lippincott William and Wilkins, Philadelphia, 2004, 179-241.
- 3. Sriram B, Agarwal PK, Tee NW et al. – Systemic candidiasis in extremely low birthweight (ELBW) Neonates despite the routine use of topical miconazole prophylaxis: trends, risk factors and outcomes over an 11-year period. Ann Acad Med Singapore, 2014;43(5):255-262.
- 4. Al-Badr AA – Miconazole nitrate: comprehensive profile, Profiles Drug Subst Excip Relat Methodol. 2005;32:3-65.
- 5. Stella VJ, He Q – Cyclodextrins. Exp Toxicol Pathol. 2008;36(1):30-42.
- 6. Szejtli J – Cyclodextrin inclusion complexes. In Cyclodextrin technology. Springer, Dordrecht, 1998, 79-185.
- 7. Loftsson T, Brewster ME – Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017-1025.
- 8. Szente L, Szejtli J – Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev. 1999;36(1):17-28.
- 9. Loftsson T, Hreinsdóttir D, Másson M – Evaluation of cyclodextrinsolubilization of drugs. Int J Pharm. 2005;302(1-2):18-28.
- 10. Rai VK, Dwivedi H, Yadav NP et al - Solubility enhancement of miconazole nitrate: binary and ternary mixture approach. Drug Dev Ind Pharm. 2014;40(8):1021-1029.
- 11. Höhne G, Hemminger WH,. Flammersheim HJ – Theoretical fundamentals of differential scanning calorimeters. Differential Scanning Calorimetry. Springer, Berlin, Heidelberg, 1996, 21-40.
- 12. Mura P, Maestrelli F, Cirri M et al – Differential scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interactions. J Therm Anal Calorim.. 2003;73(2):635-646.
- 13. Yurtdaş G, Demirel M, Genç L – Inclusion complexes of fluconazole with β-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation. J Incl Phenom Macrocycl Chem. 2011;70(3-4):429-435.
- 14. Kelemen H, Csillag A, Hancu G et al – Characterization of inclusion complexes between bifonazole and different cyclodextrins in solid and solution state. Maced J Chem Chen En. 2017;36(1):81-91.
- 15. Jug M, Mennini N, Kövér KE et al. – Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state. J Pharm Biomed Anal. 2014;91:81-91.
- 16. Ramos JJM, Diogo HP–The slow relaxation dynamics in active pharmaceutical ingredients studied by DSC and TSDC: voriconazole, miconazole and itraconazole. Int J Pharm. 2016;501(1-2): 39-48.
- 17. Ribeiro A, Figueiras A, Santos D et al – Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-β-cyclodextrin.AAPS PharmSciTech. 2008;9(4):1102-1109.
- 18. Ziemons E, Bourichi H, Mantanus J et al – Determination of binary polymorphic mixtures of fluconazole using near infrared spectroscopy and X-ray powder diffraction: a comparative study based on the pre-validation stage results. J Pharm Biomed Anal. 2011;55(5):1208-1212.
- 19. Orgován G, Kelemen H, Noszál B – Protonation and β-cyclodextrin complex formation equilibria of fluconazole. J Incl Phenom Macrocycl Chem. 2016;84(3-4):189-196.
- 20. Wang JH, Cai Z – Investigation of inclusion complex of miconazole nitrate with β-cyclodextrin. Carbohydrate polymers. 2008;72(2): 255-260.
- 21. Gupta HKK – Solid state compatibility studies of miconazole using thermal and spectroscopic methods. Adv Anal Chem. 2015;5(3):51-55.
- 22. Barillaro V, Dive G, Ziémons et al. – Theoretical and experimental vibrational study of miconazole and its dimers with organic acids: Application to the IR characterization of its inclusion complexes with cyclodextrins. . Int J Pharm. 2008;350(1-2):155-165.
- 23. Trandafirescu C, GyéresiÁ, Szabadai Z et al. – Solid-state characterization of bifonazole-betacyclodextrin binary systems. Note I. Farmacia. 2014;62(3):513-523.